A recent study published in Open Forum Infectious Diseases found that fewer than half of high-risk patients received recommended antiviral medication when seeking outpatient flu treatment. According to the Centers for Disease Control and Prevention, oseltamivir should be given “as soon as possible” to people at higher risk for flu complications, including those over 64, children under 2, and people with conditions such as asthma or heart disease. However, only 42% of high-risk patients started the medication during the 2023-2024 and 2024-2025 flu seasons, and just 42% completed the full course of treatment.
The research team, led by CDC scientists, also found significant differences in treatment rates depending on where patients received care. Emergency department patients were least likely to start the medication, with only 27% beginning treatment compared to 50% of those seeking care at non-emergency facilities like walk-in clinics. Children under age 2 were the least likely group to complete the full oseltamivir course. The study was conducted at academic medical centers in Tennessee, New York City, and Missouri, so results may vary in other settings.
Source: Read the full story at CIDRAP
This summary was written with AI assistance from the linked source.






